HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Peter K Kaiser Selected Research

Macular Degeneration (Age-Related Maculopathy)

1/2016Therapeutic Monoclonal Antibodies and Fragments: Ranibizumab.
5/2015Current phase 1/2 research for neovascular age-related macular degeneration.
3/2015Prevalence of outer retinal tubulation after anti-VEGF therapy for age-related macular degeneration.
1/2015A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis.
6/2014A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis.
1/2014Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
12/2013Aflibercept for the treatment of age-related macular degeneration.
10/2013Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study.
9/2013Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.
6/201316 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Peter K Kaiser Research Topics

Disease

53Macular Degeneration (Age-Related Maculopathy)
01/2016 - 03/2003
23Choroidal Neovascularization
01/2016 - 03/2005
15Macular Edema
01/2016 - 07/2002
12Endophthalmitis (Ophthalmia)
01/2009 - 01/2003
11Retinal Perforations
06/2015 - 11/2006
10Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016 - 07/2007
9Uveitis
10/2011 - 07/2002
6Hemorrhage
11/2011 - 07/2002
5Inflammation
12/2012 - 12/2004
4Retinal Vein Occlusion
01/2016 - 06/2005
4Wounds and Injuries (Trauma)
01/2014 - 02/2008
4Retinal Detachment (Retinal Detachments)
02/2010 - 09/2006
3Myopia
01/2016 - 03/2003
3Posterior Uveitis
10/2011 - 10/2008
2Vitreous Detachment (Posterior Vitreous Detachment)
12/2013 - 11/2013
2Vitreous Hemorrhage
01/2012 - 11/2007
2Neoplasms (Cancer)
05/2011 - 11/2006
2Cataract (Cataracts)
11/2007 - 05/2005
2Cicatrix (Scar)
10/2007 - 12/2004
2Retinitis
06/2007 - 02/2007
2Ischemia
04/2007 - 11/2006
2Iritis
12/2004 - 11/2003
2Histoplasmosis
01/2004 - 03/2003
1Central Serous Chorioretinopathy
01/2015
1Refractive Errors (Refractive Error)
01/2013
1Colorectal Neoplasms (Colorectal Cancer)
11/2012
1Neovascular Glaucoma
01/2012
1Retinal Neovascularization
01/2012
1Atrophy
05/2011
1Nevus (Nevi)
05/2011
1Melanoma (Melanoma, Malignant)
05/2011
1Epiretinal Membrane (Epiretinal Membranes)
12/2010
1Glaucoma
08/2008
1Eye Pain
11/2007
1Fibrosis (Cirrhosis)
10/2007
1Necrosis
06/2007
1Mixed Connective Tissue Disease (MCTD)
04/2007
1Vasculitis (Vasculitides)
04/2007
1Retinal Vasculitis
04/2007
1Systemic Vasculitis
04/2007
1Retinal Hemorrhage
04/2007
1Cytomegalovirus Retinitis
02/2007
1Retinal Artery Occlusion
12/2004
1Optic Neuritis (Retrobulbar Neuritis)
12/2004
1Pain (Aches)
11/2003
1St. Louis Encephalitis
11/2003
1Choroiditis
03/2003

Drug/Important Bio-Agent (IBA)

26ranibizumab (Lucentis)FDA Link
01/2016 - 10/2006
20Retinaldehyde (Retinal)IBA
03/2015 - 07/2002
18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 10/2006
12afliberceptIBA
10/2015 - 03/2012
12verteporfin (Visudyne)FDA Link
05/2012 - 03/2003
8bevacizumabFDA Link
01/2015 - 04/2007
61-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2012 - 12/2007
6Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
02/2008 - 11/2003
5Triamcinolone (Aristocort)FDA Link
02/2008 - 07/2002
4Fluorescein (Funduscein)FDA LinkGeneric
01/2012 - 11/2003
4SteroidsIBA
11/2006 - 12/2004
3Fluocinolone Acetonide (Capex)FDA LinkGeneric
10/2011 - 02/2007
2Angiogenesis InhibitorsIBA
01/2016 - 10/2006
2salicylhydroxamic acid (SHAM)IBA
10/2007 - 10/2006
2anecortave acetateIBA
01/2007 - 02/2006
1Complement System Proteins (Complement)IBA
01/2016
1Ophthalmic Solutions (Eye Drops)IBA
05/2015
1Insulin (Novolin)FDA Link
02/2015
1eplerenone (Inspra)FDA LinkGeneric
01/2015
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2015
1pegaptanibFDA Link
11/2012
1ArgonIBA
01/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2011
1Small Interfering RNA (siRNA)IBA
07/2010
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
07/2010
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2010
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2009
1chinese inkIBA
12/2008
1PlacebosIBA
10/2007
1Carbon MonoxideIBA
09/2007
1Multifocal choroiditisIBA
12/2004
1tranilast (N 5')IBA
11/2003
1Penicillins (Penicillin)FDA Link
01/2003

Therapy/Procedure

11Vitrectomy
01/2014 - 11/2006
9Intravitreal Injections
05/2015 - 11/2003
8Injections
08/2012 - 10/2006
8Photochemotherapy (Photodynamic Therapy)
05/2012 - 03/2003
7Traction
06/2015 - 09/2006
5Lasers (Laser)
10/2015 - 11/2006
5Light Coagulation
10/2015 - 11/2006
2Radiotherapy
09/2013 - 06/2009
2Cataract Extraction
08/2007 - 12/2004
1Surgical Instruments (Clip)
01/2014
1Retreatment
12/2012
1Vitreoretinal Surgery
12/2010
1Catheters
12/2008
1Replantation
10/2008
1Filtering Surgery
08/2008
1Intraocular Injections
11/2006
1Anesthesia
07/2002